Healthpoint Biotherapeutics (Fort Worth, TX) is planning a significant upgrade to its 80,000 square foot research and manufacturing facility in Ft. Worth, TX. The new, state-of-the-art facilities will comprise 25,000 square feet of manufacturing infrastructure, labs, and clean room space for the production of cell-based therapies.

  The facility upgrade comes as the company is engaged in developing a pipeline of next generation wound care therapies based on cell and cell-matrix biology. The advanced nature of the facility will provide efficient and scalable manufacturing capabilities to support both development and future commercialization, as well as create a unique environment for novel collaboration and identification of new technologies.

  Healthpoint Biotherapeutics is planning to invest approximately $60 million to build out and staff the research and manufacturing facility over the next few years. The company plans to add a total of 51 new employees in research and development, quality assurance and quality control, operations, and information technology, with 31 of these hires planned for 2012.

  Visit http://www.Healthpointbio.com for more information.